February 23, 2021 : Issue #1109

TOP STORIES — Diabetes News and Research

Prevention and Delay of Type 1 Diabetes

Telemonitoring vs. Standard Care in the Management of Diabetes

Using Semaglutide and Liraglutide To Protect the Kidney?

MOST POPULAR ARTICLES OF THE MONTH

#1 Brain Damage Associated with High Blood Glucose

#2 Critical Changes to the 2021 ADA Standards of Care

#3 Fasting Glucose Variation Predicts Microvascular Risk

We all know the value of the combination of an insulin pump and a continuous glucose monitor for improving TIR and A1c. The effects are increased if the smart technologies of the combination are used. However, not everyone can afford to use that combination, and a lot of health plans don’t pay for that technology.

This week Eric Cheung, USF Doctor of Pharmacy Candidate, shares an exciting study that uses automated Telehealth services to calculate insulin dosing for patients. The results are pretty amazing. Read Eric’s review and then think if you have patients that could benefit from the service.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

Does sustained elevated BMI accelerate the progression of islet autoimmunity in people not yet diagnosed with diabetes?

Self-management of diabetes can be more successful when telemonitoring is included.

A two-for-one deal: both cardiovascular benefits and renal protection.